Private company

GV 2019, L.P.

American company, incorporated in Delaware. Summary from the record

Last updated Oct 21, 2026.

Overview

HeadquartersDE¹

See how the biggest companies compare on our leaderboards

Corporate structure

GV 2019, L.P. sits at the top of its group. 6 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

GV 2019, L.P. DE
- EQRx, Inc. Stake · Cambridge, Massachusetts
- Invivyd, Inc. Stake · New Haven, Connecticut
- Life Technologies Stake · Carlsbad, California, United States
- Maze Therapeutics, Inc. Stake · South San Francisco, California
- Prime Medicine, Inc. Stake · Cambridge, Massachusetts

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (5 companies). Each entity in the chart links to its source.

Stakes it holds

GV 2019, L.P. has told the SEC it owns more than 5% of 5 companies, latest first (Schedules 13D and 13G).

Life TechnologiesSCHEDULE 13G/A May 1, 2026 to Aug 7, 2026²
Maze Therapeutics, Inc.SCHEDULE 13G/A May 9, 2025 to Feb 6, 2026³
Prime Medicine, Inc.SCHEDULE 13G/A Feb 10, 2023 to Nov 12, 2025⁴
Invivyd, Inc.SC 13G/A Feb 14, 2022 to Nov 8, 2024⁵
EQRx, Inc.SC 13G Feb 14, 2022⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARGV 2019, L.P. filings on SEC EDGAR
2
SEC EDGARGV 2019, L.P. SCHEDULE 13G/A on Life Technologies
3
SEC EDGARGV 2019, L.P. SCHEDULE 13G/A on Maze Therapeutics, Inc.
4
SEC EDGARGV 2019, L.P. SCHEDULE 13G/A on Prime Medicine, Inc.
5
SEC EDGARGV 2019, L.P. SC 13G/A on Invivyd, Inc.
6
SEC EDGARGV 2019, L.P. SC 13G on EQRx, Inc.